Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Fatigue and nausea are among the most common side effects of Wegovy (semaglutide), largely because the medication slows stomach emptying, suppresses appetite, and can lead to reduced calorie intake, dehydration, and lower blood sugar, all of which drain energy. These symptoms often peak in the first few weeks and after each dose increase, then ease as your body adapts, though eating smaller low-fat meals, staying hydrated, and avoiding lying down right after eating can help. Certain factors matter more than others, including dose escalation speed, other medications, and warning signs like severe abdominal pain, persistent vomiting, or dizziness that may point to gallbladder issues, pancreatitis, or dehydration. See below to understand more, as some details could change how you handle your next dose.
Because tiredness and nausea can stem from your medication, a nutrition gap, or something unrelated that needs prompt attention, guessing is rarely the fastest route to relief. A free, instant, online symptom check can help you sort likely causes, spot red flags worth urgent care, and walk into your next appointment with clear questions and a smarter plan.
Last reviewed for medical accuracy: 09/13/2026
Why does Wegovy make me so tired and nauseous all the time?
Keyword: wegovy side effects
Wegovy (semaglutide) is a once-weekly injectable medication approved for chronic weight management. It works by mimicking a hormone called GLP-1 (glucagon-like peptide-1), which helps control appetite and blood sugar. While many people see significant benefits, feeling tired and nauseous are among the most commonly reported wegovy side effects. Understanding why these symptoms occur—and how to ease them—can help you stick with your plan and feel more comfortable.
How Wegovy works
• Slowed gastric emptying: Semaglutide delays how quickly food leaves your stomach. You feel full longer, eat less, and lose weight. But a slower-emptying stomach can cause nausea, bloating or even vomiting, especially in the first weeks of treatment.
• Appetite regulation in the brain: By activating GLP-1 receptors in areas that control hunger, Wegovy reduces your appetite. That signal shift can temporarily leave you feeling low on energy as your body adjusts to fewer calories.
• Blood sugar effects: Wegovy lowers blood sugar by enhancing insulin release and suppressing glucagon. If you’re also on diabetes medications, there’s a small risk of low blood sugar (hypoglycemia), which can cause fatigue, sweating or dizziness.
Why fatigue and nausea happen together
Fatigue and nausea may feel like separate issues, but they often share underlying causes when you start Wegovy:
Calorie reduction
• Rapid drop in calorie intake can leave you low on fuel until your body adapts to using fat stores more efficiently.
• Temporary energy shortfall often leads to tiredness, lightheadedness or difficulty concentrating.
Slowed digestion
• Food sits in your stomach longer, which can trigger queasiness and reduce the amount of nutrients absorbed at first.
• Less nutrient absorption means less energy.
Hormonal shifts
• GLP-1 changes how your body processes glucose and fat. As hormone levels rebound and stabilize, you may feel off for a few days after each dose, especially during dose increases.
Dehydration and electrolyte imbalance
• Feeling full sooner may make you drink less water.
• Vomiting or diarrhea—other possible wegovy side effects—can upset your fluid and mineral balance, intensifying both nausea and fatigue.
Dose titration schedule
• Wegovy dosing starts low and increases every 4 weeks until you reach 2.4 mg.
• Each jump in dose can briefly worsen side effects as your body adjusts to a stronger GLP-1 signal.
Timeline: When to expect changes
• Week 1–4 (starting dose, 0.25 mg): Most people report mild nausea or feeling tired for a few hours to days after their shot. Symptoms often ease as your body adapts.
• Week 5–8 (0.5 mg): You may see a repeat of early symptoms, though usually less intense.
• Weeks 9–16 (1.0 mg to 1.7 mg): Nausea tends to become milder, and energy levels should start normalizing.
• Week 17+ (2.4 mg maintenance): Side effects typically stabilize. If nausea or fatigue remain severe, it’s time to talk to your doctor about adjusting the plan.
Managing wegovy side effects: practical tips
While you’re on Wegovy, you can take steps to make fatigue and nausea more manageable:
• Eat smaller, more frequent meals
– Having 4–6 mini-meals a day instead of 2–3 large ones can reduce the burden on a slowed stomach.
– Choose bland, low-fat foods (e.g., crackers, rice, bananas) when you feel queasy.
• Stay hydrated
– Sip water, herbal tea or electrolyte drinks throughout the day, even if you don’t feel very hungry.
– Aim for at least 8 cups of fluid daily, more if you’re active or losing fluids through vomiting.
• Time your injections
– Some find it helps to inject Wegovy right before bed so they sleep through the peak of side effects.
– If you experience morning nausea, consider switching to evening dosing—talk to your provider first.
• Adjust your activity level
– Light exercise like walking or gentle yoga can boost your energy and help settle your stomach.
– Avoid intense workouts on days when fatigue is worst—rest is important.
• Use over-the-counter remedies carefully
– Ginger supplements, acupressure wristbands or small doses of antacids can ease nausea for some people.
– Always check with your doctor before adding any new medication or supplement.
• Monitor blood sugar if you have diabetes
– Keep a close eye on your levels, especially when symptoms of hypoglycemia (shakiness, sweating, irritability) overlap with fatigue.
– Be prepared to adjust snacks or diabetes medications under medical guidance.
When to call your doctor
Most wegovy side effects improve over time or with minor adjustments. But you should seek medical help if you experience:
• Severe, persistent nausea or vomiting that leads to dehydration
• Dizziness, palpitations or extreme fatigue suggesting low blood pressure or hypoglycemia
• Signs of pancreatitis: severe abdominal pain that radiates to your back, with or without nausea
• Any new or worsening symptoms that interfere with daily life
Free, online symptom check, using the doctor approved Ubie Symptom Checker
If you’re unsure whether your symptoms are normal or need medical care, consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Bringing it all together
Feeling tired and nauseous on Wegovy is common, especially during the early weeks and dose increases. These side effects usually stem from reduced calorie intake, slower digestion and hormone shifts. Staying hydrated, eating small meals, timing your injection and adjusting your activity can make a big difference. Most people find that fatigue and nausea lessen as their body adapts, letting them enjoy the benefits of weight loss and improved blood sugar control.
Always discuss any persistent or severe symptoms with your doctor to rule out complications and ensure you’re on the right dosing schedule. If there’s anything that could be life-threatening or seriously affecting your health, speak to a doctor right away.
(References)
* Sorli C, Harashima SI, Tsoukas GM, Unger J, Karsbøl JD, Hansen T, Bain SC. Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial. Lancet Diabetes Endocrinol. 2017 Apr;5(4):251-260. doi: 10.1016/S2213-8587(17)30013-X. Epub 2017 Jan 17. PMID: 28110911.
* Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF, STEP 1 Study Group. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021 Mar 18;384(11):989-1002. doi: 10.1056/NEJMoa2032183. Epub 2021 Feb 10. PMID: 33567185.
* Frías JP, Davies MJ, Rosenstock J, Pérez Manghi FC, Fernández Landó L, Bergman BK, Liu B, Cui X, Brown K, SURPASS-2 Investigators. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021 Aug 5;385(6):503-515. doi: 10.1056/NEJMoa2107519. Epub 2021 Jun 25. PMID: 34170647.
* Smits MM, Van Raalte DH. Safety of Semaglutide. Front Endocrinol (Lausanne). 2021;12:645563. doi: 10.3389/fendo.2021.645563. Epub 2021 Jul 7. PMID: 34305810; PMCID: PMC8294388.
* Doggrell SA. Retatrutide showing promise in obesity (and type 2 diabetes). Expert Opin Investig Drugs. 2023 Jul-Dec;32(11):997-1001. doi: 10.1080/13543784.2023.2283020. Epub 2023 Nov 24. PMID: 37947489.
* Gudzune KA, Kushner RF. Medications for Obesity: A Review. JAMA. 2024 Aug 20;332(7):571-584. doi: 10.1001/jama.2024.10816. PMID: 39037780.
* Moiz A, Filion KB, Toutounchi H, Tsoukas MA, Yu OHY, Peters TM, Eisenberg MJ. Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes : A Systematic Review of Randomized Controlled Trials. Ann Intern Med. 2025 Feb;178(2):199-217. doi: 10.7326/ANNALS-24-01590. Epub 2025 Jan 7. PMID: 39761578.
* Thomsen RW, Mailhac A, Løhde JB, Pottegård A. Real-world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP-1RA-based weight-loss therapies. Diabetes Obes Metab. 2025 Apr;27 Suppl 2(Suppl 2):66-88. doi: 10.1111/dom.16364. Epub 2025 Apr 8. PMID: 40196933; PMCID: PMC12000858.
* Pourabhari Langroudi A, Chen AL, Basran S, Sommer ER, Stinson J, Cheng YS, Del Giuduce F, Scott M, Eisenberg ML. Male sexual dysfunction associated with GLP-1 receptor agonists: a cross-sectional analysis of FAERS data. Int J Impot Res. 2025 Aug;37(8):661-667. doi: 10.1038/s41443-025-01061-2. Epub 2025 Apr 16. PMID: 40240532.
* Garvey WT, Blüher M, Osorto Contreras CK, Davies MJ, Winning Lehmann E, Pietiläinen KH, Rubino D, Sbraccia P, Wadden T, Zeuthen N, Wilding JPH, REDEFINE 1 Study Group. Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2025 Aug 14;393(7):635-647. doi: 10.1056/NEJMoa2502081. Epub 2025 Jun 22. PMID: 40544433.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.